APIX Biosciences SA
4.0 FTEAPIX Biosciences reported total assets of €5.89m at the end of the 2025 financial year (annual accounts filed with the NBB on 28 Nov 2025), with 4 full-time equivalents.
The score of APIX Biosciences shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -9 % Total assets +227 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
APIX Biosciences's annual accounts
Filed annual accounts
- Year ended 30 Apr 2025filed on 28 Nov 2025
- Year ended 30 Apr 2024filed on 29 Nov 2024
- Year ended 30 Apr 2023filed on 22 Dec 2023
- Year ended 30 Apr 2022filed on 30 Nov 2022
APIX Biosciences's financial analysis
- Solvency18.3%sector median: 61.7%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of APIX Biosciences
APIX Biosciences's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0771.667.563
- VAT number
- BE0771667563
- Peppol
- Registered · 0208:0771667563 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 23 Jul 2021
- Registered office
- 8750 Wingene
- Size
- Micro · 4.0 FTE
- Latest accounts
- 2025 · filed on 28 Nov 2025
- Activity
- Research and experimental development on biotechnology (NACE 72101)
APIX Biosciences (SA) has been based in Wingene since 2021, active in: research and experimental development on biotechnology. For 2025, it reports a net loss of 620,962 € and equity of €1.08m; its revenue is not published. With 4.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 18.3%, below the median of its sector (61.7%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to APIX Biosciences
Companies in the same business, of comparable size and area, outside its group.
- Dendrogenix Research and experimental development on natural sciences and engineering Liège · balance sheet €5.28m
- H2WIN Research and experimental development on natural sciences and engineering Nivelles · balance sheet €7.36m
- Novobiom Research and experimental development on natural sciences and engineering Liège · balance sheet €3.92m
- Allegro Research and experimental development on natural sciences and engineering Antwerp · balance sheet €6.30m
- ConvEyXo Research and experimental development on natural sciences and engineering Charleroi · balance sheet €10.3m
- Celyad Oncology Research and experimental development on natural sciences and engineering Mont-Saint-Guibert · balance sheet €4.03m
- Aboleris Holdco Research and experimental development on natural sciences and engineering Charleroi · balance sheet €14.8m
- ProDigest Research and experimental development on natural sciences and engineering Ghent · balance sheet €7.83m
Frequently asked questions about APIX Biosciences
What is the revenue of APIX Biosciences?
APIX Biosciences files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of APIX Biosciences?
In Belgium, the VAT number is the company number prefixed with BE: BE0771667563 for APIX Biosciences, if the company is VAT-registered. Its company number (CBE) is 0771.667.563.
Where is the registered office of APIX Biosciences?
According to the CBE register, the registered office of APIX Biosciences is in 8750 Wingene.
What is the equity of APIX Biosciences?
At the close of the 2025 financial year, the equity of APIX Biosciences amounts to 1,076,629 €, a solvency of 18.3% of total assets.
How many people work at APIX Biosciences?
4.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages APIX Biosciences?
The register lists 9 active mandates at APIX Biosciences. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of APIX Biosciences
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →